Cornerstone Capital Management Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Cornerstone Capital Management Holdings's BIIB Position: Q4 2017 in Review
Cornerstone Capital Management Holdings increased its Biogen (BIIB) stake by 4.5% in Q4 2017, buying an estimated $627K and bringing the position to 45,202 shares worth $14.4M. The position accounts for 0.1% of the portfolio, ranked #223.
Cornerstone Capital Management Holdings first reported a position in BIIB in Q2 2013 and has held it in 19 quarters since. The position peaked at $44.9M in Q1 2015. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.
- Cornerstone Capital Management Holdings held 45,202 shares of Biogen worth $14.4M as of Q4 2017.
- Cornerstone Capital Management Holdings bought 1,955 Biogen shares in Q4 2017, an estimated $627K.
- Biogen made up 0.1% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #223 holding.
- Cornerstone Capital Management Holdings first reported a position in Biogen in Q2 2013 and has held it in 19 quarters since.
- Cornerstone Capital Management Holdings's Biogen position peaked at $44.9M in Q1 2015.
- 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.
Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.